Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A02253 | Pages: 243 | Charts: 24 | Tables: 114 |
The global minimally invasive surgery market was valued at $60,643.0 million in 2020, and is estimated to reach $94,421.7 million by 2030, growing a CAGR of 4.7% from 2021 to 2030. Minimally invasive surgery is defined as the surgical procedure conducted through small incision in place of large opening. A surgeon uses a wide range of technique to operate with minimally damage to the body.
[COVIDIMPACTSTATEMENT]
Minimally invasive surgery is associated with less pain, fewer complications and shorter hospital stay. Surgeries such as cardiothoracic surgery, gastroesophageal reflux disease, gastroenterology, gynecological surgery, heart surgery, pediatric surgery, urogynecology and pelvic reconstructive surgery, and urological surgery are conducted through minimally invasive surgical procedures. Both diagnostic and treatment surgeries can be performed with minimally invasive surgery.
Get more information on this report : Request Sample Pages
Growth of the global Minimally invasive surgery market is majorly driven by increase in prevalence of chronic diseases such as gastrointestinal disease, kidney disease, heart disease, and respiratory disease; rise in demand for Minimally invasive surgery; increase in funding from private & government organizations for development of healthcare infrastructure; and advancements in technologies in the field of Minimally invasive surgery. According to the World Health Organization (WHO) in 2021, various types of chronic diseases, such as cardiovascular diseases, cancer, respiratory diseases, and diabetes are responsible for approximately 17.9 million, 9.3 million, 4.1 million, and 1.5 million deaths, respectively. As per the same source, 41 million people die each year due to chronic disease, which is equivalent to 71% of all deaths, globally. Furthermore, surge in demand for laparoscopic surgery is anticipated to fuel growth of the minimally invasive surgery market. For instance, in April 2021, Genesis MedTech, a medical device company, announced launch of novel laparoscopic technology in Singapore and China. This technology allows physicians to conduct Minimallyly invasive surgery instead of open surgery in complicated procedures to reduce risk of patients and enhance recovery time.
In addition, rise in geriatric population fuels the minimally invasive surgery market growth, owing to the fact that aged individuals are more susceptible to chronic diseases. Moreover, rise in number of surgeries boost growth of the market. According to the World Health Organization (WHO), in 2019, it was reported that around 235 million major surgeries are conducted every year across the globe. Further, in March 2021, the U.S. Food and Drug Administration (USFDA) announced that they have given authorized marketing approval to the Hominis Surgical System, a new robotically-assisted surgical device (RASD), which can help facilitate transvaginal hysterectomy in certain patients.
Thus, technological advancements in robotic assistive technology and rise in awareness among individuals regarding advantages of minimally invasive surgery propels growth of the market. However, high cost associated with minimally invasive surgical procedures is expected to restrict the minimally invasive surgery market growth during the forecast period.
The global minimally invasive surgery market is segmented into service type, condition, end user, and region. By service type, the market is categorized into laparoscopic surgery, and robotic surgery. The laparoscopic surgery segment is further classified into appendectomy, hysterectomy, myomectomy, colectomy, and others. Further, the robotic surgery services segment is classified into colorectal surgery, gynecologic surgery, and others.
Depending on condition, it is categorized into gastrointestinal conditions, spinal conditions, gynecologic conditions, and other conditions. By end user, the market is fragmented into hospitals & clinics and ambulatory surgical centers.
[SERVICETYPEGRAPH]
Get more information on this report : Request Sample Pages
Region wise, the minimally invasive surgery market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Depending on service type, the laparoscopic surgery segment dominated the minimally invasive surgery market in 2020, and this trend is expected to continue during the forecast period, owing to advancement in minimally invasive surgery technology in healthcare sector, increase in demand for laparoscopic surgery, and rise in number of surgical procedure. However, the robotic surgery segment is expected to witness considerable growth during the forecast period, owing to technological advancement in robotic assisted surgery, increase in number of approval, and distribution agreement of the robotic surgery systems in the hospitals and clinics.
[CONDITIONGRAPH]
Get more information on this report : Request Sample Pages
On the basis of condition, the gynecologic conditions segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in incidence of gynecology disorder, rise in female population and stringent government regulations to develop advanced minimally invasive surgical instruments. However, the spinal condition segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of axial spondyloarthritis, and advancements in technology in healthcare sector.
By end user, the hospitals & clinics segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in number of hospitals and initiatives taken by governments for development of healthcare infrastructure. However, the ambulatory surgical center segment is expected to witness considerable growth during the forecast period, owing to initiatives taken by governments for advancement of ambulatory surgical centers, surge in demand for minimally invasive surgery, and rise in prevalence of chronic diseases.
[ENDUSERGRAPH]
Get more information on this report : Request Sample Pages
North America garnered the major share in the Minimally invasive surgery market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of chronic diseases, presence of key players, development of the healthcare sector, and advancements in technology for diagnostic instruments in the region. However, Asia-Pacific is expected to register highest CAGR of 5.7% from 2021 to 2030, owing to increase in number of surgical procedures, rise in demand for minimally invasive surgery, improvement in healthcare infrastructure, and technological advancements in minimally invasive surgical instruments.
The key players operating in the global Minimally invasive surgery market include Apollo Hospitals Enterprise Ltd, Bedfordshire Hospitals, Circle Health Ltd, Manipal Health Enterprises Pvt Ltd, King Fahd Medical City, Mount Elizabeth Hospital, Singapore General Hospital Ltd, Stanford Healthcare, The General Hospital Corporation, and The Johns Hopkins Hospital.
[REGIONGRAPH]
Get more information on this report : Request Sample Pages
Minimally Invasive Surgery Market Research Study Key Benefits:
Key Market Segments
By Service Type
By Condition
By End User
By Region
Key Market Players
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in prevalence of lifestyle and chronic diseases
3.5.1.2.Technological advancements of MIS instruments
3.5.1.3.Rising demand and benefits of minimally invasive surgery
3.5.2.Restraint
3.5.2.1.High cost of diagnostic instruments
3.5.3.Opportunity
3.5.3.1.Growing trend of medical tourism
3.5.3.2.Increasing adoption of robotic surgeries in emerging economies
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the Minimally invasive surgery market
CHAPTER 4:MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Laparoscopic Surgery
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Laparoscopic Surgery, by type
4.2.2.1.Market size and forecast
4.2.2.2.Appendectomy
4.2.2.2.1.Market size and forecast
4.2.2.3.Hysterectomy
4.2.2.3.1.Market size and forecast
4.2.2.4.Myomectomy
4.2.2.4.1.Market size and forecast
4.2.2.5.Colectomy
4.2.2.5.1.Market size and forecast
4.2.2.6.Others
4.2.2.6.1.Market size and forecast
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Robotic Surgery
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Robotic surgery, by type
4.3.2.1.Market size and forecast
4.3.2.2.Colorectal surgery
4.3.2.2.1.Market size and forecast
4.3.2.3.Gynecologic surgery
4.3.2.3.1.Market size and forecast
4.3.2.4.Others
4.3.2.4.1.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
CHAPTER 5:MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION
5.1.Overview
5.1.1.Market size and forecast
5.2.Gastrointestinal Conditions
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Spinal Conditions
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
5.4.Gynecologic Conditions
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
5.5.Others
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country
CHAPTER 6:MINIMALLY INVASIVE SURGERY MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals and Clinics
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Ambulatory Surgical Centers
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
CHAPTER 7:MINIMALLY INVASIVE SURGERY MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America minimally invasive surgery market, by service type
7.2.3.North America minimally invasive surgery market, by condition
7.2.4.North America minimally invasive surgery market, by end user
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.U.S. minimally invasive surgery market, by service type
7.2.5.1.2.U.S. minimally invasive surgery market, by condition
7.2.5.1.3.U.S. minimally invasive surgery market, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada minimally invasive surgery market, by service type
7.2.5.2.2.Canada minimally invasive surgery market, by condition
7.2.5.2.3.Canada minimally invasive surgery market, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico minimally invasive surgery market, by service type
7.2.5.3.2.Mexico minimally invasive surgery market, by condition
7.2.5.3.3.Mexico minimally invasive surgery market, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe minimally invasive surgery market, by service type
7.3.3.Europe minimally invasive surgery market, by condition
7.3.4.Europe minimally invasive surgery market, by end user
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Germany minimally invasive surgery market, by service type
7.3.5.1.2.Germany minimally invasive surgery market, by condition
7.3.5.1.3.Germany minimally invasive surgery market, by end user
7.3.5.2.France
7.3.5.2.1.France minimally invasive surgery market, by service type
7.3.5.2.2.France minimally invasive surgery market, by condition
7.3.5.2.3.France minimally invasive surgery market, by end user
7.3.5.3.UK
7.3.5.3.1.UK minimally invasive surgery market, by service type
7.3.5.3.2.UK minimally invasive surgery market, by condition
7.3.5.3.3.UK minimally invasive surgery market, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy minimally invasive surgery market, by service type
7.3.5.4.2.Italy minimally invasive surgery market, by condition
7.3.5.4.3.Italy minimally invasive surgery market, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain minimally invasive surgery market, by service type
7.3.5.5.2.Spain minimally invasive surgery market, by condition
7.3.5.5.3.Spain minimally invasive surgery market, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe minimally invasive surgery market, by service type
7.3.5.6.2.Rest of Europe minimally invasive surgery market, by condition
7.3.5.6.3.Rest of Europe minimally invasive surgery market, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific minimally invasive surgery market, by service type
7.4.3.Asia-Pacific minimally invasive surgery market, by condition
7.4.4.Asia-Pacific minimally invasive surgery market, by end user
7.4.5.Market size and forecast, by country
7.4.5.1.Japan
7.4.5.1.1.Japan minimally invasive surgery market, by service type
7.4.5.1.2.Japan minimally invasive surgery market, by condition
7.4.5.1.3.Japan minimally invasive surgery market, by end user
7.4.5.2.China
7.4.5.2.1.China minimally invasive surgery market, by service type
7.4.5.2.2.China minimally invasive surgery market, by condition
7.4.5.2.3.China minimally invasive surgery market, by end user
7.4.5.3.Australia
7.4.5.3.1.Australia minimally invasive surgery market, by service type
7.4.5.3.2.Australia minimally invasive surgery market, by condition
7.4.5.3.3.Australia minimally invasive surgery market, by end user
7.4.5.4.India
7.4.5.4.1.India minimally invasive surgery market, by service type
7.4.5.4.2.India minimally invasive surgery market, by condition
7.4.5.4.3.India minimally invasive surgery market, by end user
7.4.5.5.South Korea
7.4.5.5.1.South Korea minimally invasive surgery market, by service type
7.4.5.5.2.South Korea minimally invasive surgery market, by condition
7.4.5.5.3.South Korea minimally invasive surgery market, by end user
7.4.5.6.Rest of Asia-Pacific
7.4.5.6.1.Rest of Asia-Pacific minimally invasive surgery market, by service type
7.4.5.6.2.Rest of Asia-Pacific minimally invasive surgery market, by condition
7.4.5.6.3.Rest of Asia-Pacific minimally invasive surgery market, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA minimally invasive surgery market, by service type
7.5.3.LAMEA minimally invasive surgery market, by condition
7.5.4.LAMEA minimally invasive surgery market, by end user
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil
7.5.5.1.1.Brazil minimally invasive surgery market, by service type
7.5.5.1.2.Brazil minimally invasive surgery market, by condition
7.5.5.1.3.Brazil minimally invasive surgery market, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia Minimally invasive surgery market, by service type
7.5.5.2.2.Saudi Arabia Minimally invasive surgery market, by condition
7.5.5.2.3.Saudi Arabia Minimally invasive surgery market, by end user
7.5.5.3.South Africa
7.5.5.3.1.South Africa minimally invasive surgery market, by service type
7.5.5.3.2.South Africa minimally invasive surgery market, by condition
7.5.5.3.3.South Africa minimally invasive surgery market, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA minimally invasive surgery market, by service type
7.5.5.4.2.Rest of LAMEA minimally invasive surgery market, by condition
7.5.5.4.3.Rest of LAMEA minimally invasive surgery market, by end user
CHAPTER 8:COMPANY PROFILES
8.1.APOLLO HOSPITALS ENTERPRISE LTD
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.BEDFORDSHIRE HOSPITALS
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product portfolio
8.3.CIRCLE HEALTH LTD
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.MANIPAL HEALTH ENTERPRISES PVT LTD
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Product portfolio
8.4.4.Key strategic moves and developments
8.5.KING FAHD MEDICAL CITY
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Product portfolio
8.6.MOUNT ELIZABETH HOSPITAL
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.Singapore General Hospital Ltd
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Product portfolio
8.8.Stanford Healthcare
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Product portfolio
8.8.4.Business performance
8.9.The General Hospital Corporation
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.10.The Johns Hopkins Hospital
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
LIST OF TABLES
TABLE 01.GLOBAL MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020–2030 ($MILLION)
TABLE 02.LAPAROSCOPIC SURGERY MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 03.MINIMALLY INVASIVE SURGERY MARKET FOR LAPAROSCOPIC SURGERY, BY REGION, 2020–2030 ($MILLION)
TABLE 04.ROBOTIC SURGERY MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 05.MINIMALLY INVASIVE SURGERY MARKET FOR ROBOTIC SURGERY, BY REGION, 2020–2030 ($MILLION)
TABLE 06.GLOBAL MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 07.MINIMALLY INVASIVE SURGERY MARKET FOR GASTROINTESTINAL CONDITIONS, BY REGION, 2020–2030 ($MILLION)
TABLE 08.MINIMALLY INVASIVE SURGERY MARKET FOR SPINAL CONDITIONS, BY REGION, 2020–2030 ($MILLION)
TABLE 09.MINIMALLY INVASIVE SURGERY MARKET FOR GYNECOLOGIC CONDITIONS, BY REGION, 2020–2030 ($MILLION)
TABLE 10.MINIMALLY INVASIVE SURGERY MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 11.GLOBAL MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 12.MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2030 ($MILLION)
TABLE 13.MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGICAL CENTRES, BY REGION, 2020–2030 ($MILLION)
TABLE 14.MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15.NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE , 2020-2030 ($MILLION)
TABLE 16.NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 19.U.S. MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 20.U.S. MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 21.U.S. MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 22.CANADA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 23.CANADA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 24.CANADA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.MEXICO MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 26.MEXICO MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 27.U.S. MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 28.EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 29.EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 30.EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.GERMANY MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 33.GERMANY MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 34.GERMANY MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35.FRANCE MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 36.FRANCE MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 37.FRANCE MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.UK MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 39.UK MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 40.UK MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41.ITALY MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 42.ITALY MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 43.ITALY MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.SPAIN MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 45.SPAIN MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 46.SPAIN MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47.REST OF EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 48.REST OF EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 49.REST OF EUROPE MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50.ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 51.ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 52.ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53.ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 54.JAPAN MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 55.JAPAN MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 56.JAPAN MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57.CHINA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 58.CHINA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 59.CHINA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60.AUSTRALIA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 61.AUSTRALIA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 62.AUSTRALIA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63.INDIA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 64.INDIA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 65.INDIA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66.SOUTH KOREA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 67.SOUTH KOREA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 68.SOUTH KOREA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72.LAMEA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 73.LAMEA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 74.LAMEA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 75.LAMEA MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 76.BRAZIL MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 77.BRAZIL MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 78.BRAZIL MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79.SAUDI ARABIA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 80.SAUDI ARABIA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 81.SAUDI ARABIA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82.SOUTH AFRICA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 83.SOUTH AFRICA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 84.SOUTH AFRICA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85.REST OF LAMEA MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 86.REST OF LAMEA MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 87.REST OF LAMEA MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 88.APOLLO: COMPANY SNAPSHOT
TABLE 89.APOLLO: OPERATING SEGMENT
TABLE 90.APOLLO: PRODUCT PORTFOLIO
TABLE 91.APOLLO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92.BEDFORD HOSPITAL: COMPANY SNAPSHOT
TABLE 93.BEDFORD HOSPITAL: PRODUCT PORTFOLIO
TABLE 94.CIRCLE: COMPANY SNAPSHOT
TABLE 95.CIRCLE: OPERATING SEGMENT
TABLE 96.CIRCLE: PRODUCT PORTFOLIO
TABLE 97.CIRCLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98.MANIPAL HOSPITALS: COMPANY SNAPSHOT
TABLE 99.MANIPAL HOSPITALS: PRODUCT PORTFOLIO
TABLE 100.MANIPAL HOSPITALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101.KFMC: COMPANY SNAPSHOT
TABLE 102.KFMC: PRODUCT PORTFOLIO
TABLE 103.MOUNT ELIZABETH: COMPANY SNAPSHOT
TABLE 104.MOUNT ELIZABETH: OPERATING SEGMENT
TABLE 105.MOUNT ELIZABETH: PRODUCT PORTFOLIO
TABLE 106.SGH: COMPANY SNAPSHOT
TABLE 107.SGH: PRODUCT PORTFOLIO
TABLE 108.STANFORD: COMPANY SNAPSHOT
TABLE 109.STANFORD: PRODUCT PORTFOLIO
TABLE 110.MGH: COMPANY SNAPSHOT
TABLE 111.MGH: PRODUCT PORTFOLIO
TABLE 112.JOHNS HOPKINS: COMPANY SNAPSHOT
TABLE 113.JOHNS HOPKINS: OPERATING SEGMENT
TABLE 114.JOHNS HOPKINS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.MINIMALLY INVASIVE SURGERY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.PREVALENCE OF DIABETES IN POPULATION (MILLIONS) AND DIABETES PREVALENCE (%)
FIGURE 13.IMPACT ANALYSIS
FIGURE 14.COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE SURGERY MARKET FOR LAPAROSCOPIC SURGERY, BY COUNTRY, 2020–2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE SURGERY MARKET FOR ROBOTIC SURGERY, BY COUNTRY, 2020–2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE SURGERY MARKET FOR GASTROINTESTINAL CONDITIONS, BY COUNTRY, 2020–2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE SURGERY MARKET FOR SPINAL CONDITIONS, BY COUNTRY, 2020–2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE SURGERY MARKET FOR GYNECOLOGIC CONDITIONS, BY COUNTRY, 2020–2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE SURGERY MARKET FOR OTHERS, BY COUNTRY, 2020–2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2020–2030 (%)
FIGURE 22.APOLLO: NET SALES, 2019–2021 ($MILLION)
FIGURE 23.APOLLO: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 24.STANFORD: NET SALES, 2018–2020 ($MILLION)